|
INSE
Inspired Entertainment, Inc.
|
ROGERS DESIREE G |
Director |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
10,952 |
|
40,667 |
|
RYN
RAYONIER INC
|
Rogers W. Rhett |
Officer |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
17,932 |
|
95,115 |
|
PPL Corp
|
ROGERSON CRAIG A |
|
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
1,246 |
$35.11 |
242,538 |
|
PNR
PENTAIR plc
|
Rolchigo Philip M. |
|
1/2/2026 |
Disposition (Non Open Market) |
Direct |
35 |
$105.47 |
20,178 |
|
XMTR
Xometry, Inc.
|
Rollins Emily |
|
1/2/2026 |
Option Execute |
Direct |
1,000 |
$12.32 |
12,455 |
|
XMTR
Xometry, Inc.
|
Rollins Emily |
|
1/2/2026 |
Automatic Sell |
Direct |
1,000 |
$61.86 |
11,455 |
|
Xometry, Inc.
|
Rollins Emily |
|
1/2/2026 |
Option Execute |
Direct |
1,000 |
|
350 |
|
Evergy, Inc.
|
Rolph Jonathan D |
Director |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
414 |
|
4,561 |
|
KIMBERLY CLARK CORP
|
Romanelli Joseph |
Director |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
1,923 |
|
3,701 |
|
Silence Therapeutics plc
|
Romano Steven J. |
|
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
300,000 |
|
300,000 |
|
Summit Therapeutics Inc.
|
Ronaghi Mostafa |
Director |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
35,000 |
|
35,000 |
|
MFA FINANCIAL, INC.
|
Roper Michael Charles |
Officer |
1/2/2026 |
Disposition (Non Open Market) |
Direct |
96,268 |
|
221,481 |
|
GREIF, INC
|
ROSE B ANDREW |
Director |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
18 |
$67.70 |
2,225 |
|
TREX
TREX CO INC
|
ROSE B ANDREW |
Director |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
225 |
$35.83 |
1,803 |
|
TEXTRON INC
|
Rosenberg David Mathew |
Officer |
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
243 |
$87.05 |
243 |
|
FOLD
AMICUS THERAPEUTICS, INC.
|
Rosenberg Ellen |
|
1/2/2026 |
Disposition (Non Open Market) |
Direct |
13,426 |
$14.27 |
494,284 |
|
ACUR
ACURA PHARMACEUTICALS, INC
|
ROSS GEORGE K |
Director |
1/2/2026 |
Option Execute |
Direct |
50,000 |
|
595,903 |
|
ACURA PHARMACEUTICALS, INC
|
ROSS GEORGE K |
Director |
1/2/2026 |
Option Execute |
Direct |
50,000 |
|
0 |
|
ACURA PHARMACEUTICALS, INC
|
ROSS GEORGE K |
Director |
1/2/2026 |
Disposition (Non Open Market) |
Direct |
50,000 |
|
50,000 |
|
HUBG
Hub Group, Inc.
|
Ross Jenell |
|
1/2/2026 |
Disposition (Non Open Market) |
Direct |
1,695 |
$42.75 |
23,395 |
|
HUBG
Hub Group, Inc.
|
Ross Jenell |
|
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
4,679 |
|
28,074 |
|
Coya Therapeutics, Inc.
|
ROSS WILBUR L JR |
|
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
10,000 |
|
10,000 |
|
HURN
Huron Consulting Group Inc.
|
Roth James H |
Director |
1/2/2026 |
Disposition (Non Open Market) |
Direct |
203 |
$172.91 |
35,101 |
|
HURN
Huron Consulting Group Inc.
|
Roth James H |
Director |
1/2/2026 |
Automatic Sell |
Direct |
2,000 |
$170.26 |
33,101 |
|
VKTX
Viking Therapeutics, Inc.
|
Rouan Sarah Kathryn |
|
1/2/2026 |
Acquisition (Non Open Market) |
Direct |
3,150 |
|
4,390 |